NCT00506272

Brief Summary

ISMAS is designed to test the hypothesis that self management of insulin dependent diabetes mellitus by selected patients admitted for elective surgery is more efficacious than standard care with respect to overall glycemic control, attaining finger-stick blood sugars, and administering insulin.

Trial Health

55
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
1

participants targeted

Target at below P25 for not_applicable diabetes-mellitus

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

July 23, 2007

Completed
2 days until next milestone

First Posted

Study publicly available on registry

July 25, 2007

Completed
4 months until next milestone

Study Start

First participant enrolled

December 1, 2007

Completed
9 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 1, 2016

Completed
Last Updated

December 14, 2015

Status Verified

December 1, 2015

Enrollment Period

9 years

First QC Date

July 23, 2007

Last Update Submit

December 11, 2015

Conditions

Keywords

diabetes mellitushyperglycemiahypoglycemiaself care

Outcome Measures

Primary Outcomes (3)

  • number of blood glucose measurements obtained/number of blood glucose measurements ordered

    patients will be followed for the duration of hospital stay, an expected average of 5 days

  • number of insulin doses administered/number of insulin doses prescribed

    patients will be followed for the duration of hospital stay, an expected average of 5 days

  • average blood glucose

    patients will be followed for the duration of hospital stay, an expected average of 5 days

Study Arms (2)

Standard care

EXPERIMENTAL

Patients admitted for elective surgery will receive standard diabetes care, including but not limited to finger stick blood glucose determinations, and insulin injections delivered by the nursing staff.

Procedure: Standard care

Patient administered care

EXPERIMENTAL

Patients will self-monitor and record finger-stick blood glucose measurements, and self administer insulin at doses agreed upon with the consulting endocrinology in-patient service.

Procedure: Self blood glucose monitoring and insulin administration

Interventions

Patients will monitor blood glucose using a hand-held blood glucose monitor, and self-administer insulin

Patient administered care
Standard carePROCEDURE

finger-stick blood glucose values to be obtained and all insulin administration to be delivered by nursing staff

Standard care

Eligibility Criteria

Age18 Years - 80 Years
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • Male or female, age \< 80
  • Most recent hemoglobin A1C within the past 6 months \< 12%
  • Recent history of regular self-administered peripheral blood glucose checks as an outpatient
  • Recent history of insulin self-administration at least twice a day as an outpatient
  • Admitted for a hospitalization anticipated to last at least 3 days
  • Mini Mental Status Examination (MMSE) ≥ 25 at admission and the same or better post-operatively
  • All patients will be actively followed by the Endocrinology inpatient consultation team during the hospitalization.

You may not qualify if:

  • Currently receiving peritoneal or hemodialysis
  • Patients with unstable angina
  • History of myocardial infarction within 3 weeks prior to enrollment
  • Current admission due to or associated with altered mental status or encephalopathy
  • History of an episode of altered mental status or encephalopathy within the 4 weeks prior to enrollment
  • A confirmed diagnosis of dementia
  • Inability to self-adjust insulin
  • No recent history of ability to perform regular peripheral blood glucose checks
  • Frequency of hypoglycemia (\< 60 mg/dL) \> twice/week by history
  • Inability to eat without assistance
  • Study objectives will not be pursued in patients during stays in any intensive care unit.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Atlanta VA Medical Center

Decatur, Georgia, 30033, United States

Location

MeSH Terms

Conditions

Diabetes MellitusHyperglycemiaHypoglycemia

Interventions

Blood Glucose Self-MonitoringStandard of Care

Condition Hierarchy (Ancestors)

Glucose Metabolism DisordersMetabolic DiseasesNutritional and Metabolic DiseasesEndocrine System Diseases

Intervention Hierarchy (Ancestors)

Blood Chemical AnalysisClinical Chemistry TestsClinical Laboratory TechniquesDiagnostic Techniques and ProceduresDiagnosisDiagnostic Techniques, EndocrineMonitoring, PhysiologicSelf-TestingSelf CareTherapeuticsInvestigative TechniquesQuality Indicators, Health CareQuality of Health CareHealth Services AdministrationHealth Care Quality, Access, and Evaluation

Study Officials

  • Peter M Thule, MD

    Atlanta VA Medical Center

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
HEALTH SERVICES RESEARCH
Intervention Model
PARALLEL
Sponsor Type
FED
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Chief, Section Endocrinology

Study Record Dates

First Submitted

July 23, 2007

First Posted

July 25, 2007

Study Start

December 1, 2007

Primary Completion

December 1, 2016

Last Updated

December 14, 2015

Record last verified: 2015-12

Locations